Results 1 to 10 of about 124,250 (211)

Botulinum toxin A for the Treatment of Overactive Bladder

open access: yesToxins, 2016
The standard treatment for overactive bladder starts with patient education and behavior therapies, followed by antimuscarinic agents. For patients with urgency urinary incontinence refractory to antimuscarinic therapy, currently both American Urological
Po-Fan Hsieh   +4 more
doaj   +2 more sources

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A [PDF]

open access: yesToxins
Botulinum toxin suppresses neurotransmitter release, thereby inhibiting muscle contraction and inducing flaccid paralysis. Botulinum toxin type A (BoNT/A) is widely used for neuromuscular blockade but, upon repeated administration, may cause long-lasting
Jeong-Sun Nam   +7 more
doaj   +2 more sources

Immunogenicity of botulinum toxin [PDF]

open access: yesArchives of Plastic Surgery, 2022
Botulinum toxin treatment is the most common non-surgical cosmetic treatment. Although there are many available treatments using botulinum toxin, their effects are temporary and repeated injections are required. These frequent injections can trigger an immunological response. In addition, botulinum toxin acts as an antigen in the body; thus, its effect
Syeo Young Wee, Eun Soo Park
openaire   +3 more sources

Botulinum toxin preparations: areas for improvement and issues of standardisation

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2023
Scientific relevance. Botulinum toxin preparations are a good example of using a deadly toxin as a unique therapeutic agent. However, there are many unresolved issues related to biotechnology, biological activity, interchangeability, and standardisation ...
M. V. Savkina   +4 more
doaj   +1 more source

Wide range applications of botulinum toxin in medicine - literature review

open access: yesJournal of Education, Health and Sport, 2023
Introduction and purpose : Botulinum toxin is one of the most dangerous natural toxins. Botulinum toxin poisoning causes botulism. Botulism is a set of systemic symptoms resulting from flaccid muscle paralysis.
Aleksandra Serwik-Trandasir   +9 more
doaj   +1 more source

Isolation and typing of Clostridium botulinum from milk powder of an enterprise associated with a case of infant botulism

open access: yesZhongguo shipin weisheng zazhi, 2023
ObjectiveThe aim of this study was to detect botulinum toxin and Clostridium botulinum (C.botulinum) in 30 batches of infant formula milk powder obtained from an enterprise and to analyze the whole genome of the strain of C.
LUO Haipeng   +8 more
doaj   +1 more source

Prolonged Antipruritic Effect of Botulinum Toxin Type A on Cowhage-induced Itch: A Randomized, Single-blind, Placebo-controlled Trial

open access: yesActa Dermato-Venereologica, 2023
Botulinum toxin type A (Botox®) is thought to have antipruritic effects through inhibition of pruritic factors, including acetylcholine, substance P, and glutamate. The aim of this randomized, single-blind, placebo-controlled trial was to test the effect
Leigh A. Nattkemper   +7 more
doaj   +1 more source

A comparative study between lateral internal anal sphincterotomy and botulinum toxin injection in the treatment of chronic anal fissure

open access: yesZanco Journal of Medical Sciences, 2021
Background and objective: The gold standard for the treatment of chronic anal fissure is lateral internal sphincterotomy. Botulinum toxin injection provides temporary alleviation of sphincter spasm and allows the fissure to heal.
Abdulqadir M. Zngana, Bawan Hiwa
doaj   +1 more source

The Effects of Botulinum Toxin (BTXA) Dermal Injections on Facial Wrinkle Lines. [PDF]

open access: yesArchives of Aesthetic Plastic Surgery, 2013
Facial rejuvenation using Botulinum toxin A is one of the most popular aesthetic procedures. Many cosmetic applications of Botulinum toxin A are under evaluation.
Sung Chul Park   +3 more
doaj   +1 more source

A PRACTICAL GUIDE TO OPTIMIZING THE BENEFITS OF POST-STROKE SPASTICITY INTERVENTIONS WITH BOTULINUM TOXIN A: AN INTERNATIONAL GROUP CONSENSUS

open access: yesJournal of Rehabilitation Medicine, 2020
This consensus paper is derived from a meeting of an international group of 19 neurological rehabilitation specialists with a combined experience of more than 250 years (range 4–25 years; mean 14.1 years) in treating post-stroke spasticity with botulinum
G. Francisco   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy